NCT03242824 The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma Status COMPLETED Phase PHASE2
NCT03193463 Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy Status WITHDRAWN Phase EARLY_PHASE1
NCT03181581 Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain Tissue. Status TERMINATED Phase PHASE2
NCT03180502 Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03168919 Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma Status TERMINATED Phase NA
NCT03152318 A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03149575 VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM Status TERMINATED Phase PHASE3
NCT03134131 Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas Status NO_LONGER_AVAILABLE Phase N/A
NCT03102203 Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging Status UNKNOWN Phase N/A
NCT03095248 Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Status TERMINATED Phase PHASE2
NCT03082846 Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial Status COMPLETED Phase NA
NCT03072134 Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma Status COMPLETED Phase PHASE1
NCT03050736 Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression Status COMPLETED Phase PHASE2
NCT03030066 Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03027388 Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma Status COMPLETED Phase PHASE2